Halo nevus, rather than vitiligo, is a typical dermatologic finding of turner's syndrome: Clinical, genetic, and immunogenetic study in 72 patients

Journal of the American Academy of Dermatology

Volumn 51, Issue 3, 2004, Pages 354-358

  Brazzelli, Valeria ^a   Larizza, Daniela ^a   Martinetti, Miriam ^a   Martinoli, Sara ^a   Calcaterra, Valeria ^a   De Silvestri, Annalisa ^a   Pandolfi, Roberta ^a   Borroni, Giovanni ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

GH; growth hormone; halo nevus; HN; odds ratio; OR; organ specific autoantibodies; OSA; TS; Turner's syndrome

Indexed keywords

HLA DQB1 ANTIGEN;

ADULT; ALLELE; ARTICLE; AUTOIMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; GENE FREQUENCY; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENETICS; HALO NEVUS; HLA SYSTEM; HUMAN; IMMUNOGENETICS; KARYOTYPE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NEVUS; PREVALENCE; PRIORITY JOURNAL; TURNER SYNDROME; VITILIGO;

ADOLESCENT; ADULT; BLOOD DONORS; CHILD; CHILD, PRESCHOOL; ESTROGENS; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENES, MHC CLASS I; GENES, MHC CLASS II; GENOTYPE; HLA ANTIGENS; HUMANS; ITALY; KARYOTYPING; NEVUS, PIGMENTED; POLYMORPHISM, GENETIC; PREVALENCE; TURNER SYNDROME; VITILIGO;

EID: 4444270632     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2003.11.082     Document Type: Article

References (35)

1. Ranke M.B. An introduction to Turner's syndrome. 1989;2 Oxford Clinical Communications, Oxford
2. Saenger P. Turner syndrome. N Engl J Med. 335:1996;1749-1754
3. Bernasconi S., Larizza D., Benso L., Volta C., Vannelli S., Milani S., et al. Turner's syndrome in Italy: familial characteristics, neonatal data, standards for birth weight and for height and weight from infancy to adulthood. Acta Paediatr. 83:1994;292-298
4. Larizza D., Salvatoni A., Lorini R., Cisternino M., Livieri C., Bozzola M., et al. Croissance et maturation pubertaire dans le syndrome de Turner. Rev Int Pediatr. 131:1983;9-12
5. Borroni G., Larizza D., Vignati G., Zaccone C., Zanetta R., Vignoli G.P., et al. The dermatological spectrum of Turner syndrome. J Eur Acad Dermatol Venereol. 3:1994;334-340
6. Hall J., Gilchrist D. Turner syndrome and its variants. Pediatr Clin North Am. 37:1990;1421-1440
7. Becker B., Jospe N., Goldsmith L.A. Melanocytic nevi in Turner syndrome. Pediatr Dermatol. 11:1994;120-124
8. Zvulunov A., Wyatt D.T., Laud P.W., Esterly N.B. Influence of genetic and environmental factors on melanocytic naevi: a lesson from Turner's syndrome. Br J Dermatol. 138:1998;993-997
9. Gibbs P., Brady B.M., Gonzalez R., Robinson W.A. Nevi and melanoma: lessons from Turner's syndrome. Dermatology. 202:2001;1-3
10. Frank S.B., Cohen H.J. The halo nevus. Arch Dermatol. 89:1964;367-373
11. Bystryn J.C., Zhong X.I.E. Neoplastic hypomelanoses. Nordlund Y.J., Boissy R.E., Hearing V.J., King R.A., Ortonne J.P. The pigmentary system: physiology and pathophysiology. 1998;647-662 Oxford University Press, Oxford
12. Larsson P.A., Liden S. Prevalence of skin diseases among adolescents 12-16 years of age. Acta Derm Venereol. 60:1980;415-423
13. Nordlund J., Ortonne J.P. Vitiligo vulgaris. Nordlund Y.J., Boissy R.E., Hearing V.J., King R.A., Ortonne J.P. The pigmentary system: physiology and pathophysiology. 1998;513-551 Oxford University Press, Oxford
14. Polani P.E. Turner's syndrome and allied conditions. Br Med Bull. 17:1961;200-205
15. Lippe B.M. Primary ovarian failure. Kaplan S.A. Clinical pediatric endocrinology. 1990;325-366 Saunders Company, Philadelphia
16. Chiovato L., Larizza D., Bendelli G., Tonacchera M., Marino M., Mammoli C., et al. Autoimmune hypothyroidism and hyperthyroidism in patients with Turner's syndrome. Eur J Endocrinol. 134:1996;568-575
17. Radetti G., Mozzanti L., Paganini C., Bernasconi S., Russo G., Rigon F., et al. Frequency, clinical and laboratory features of thyroiditis in girls with Turner's syndrome. Acta Paediatr. 84:1995;909-912
18. Gruneiro de Papendieck L., Iorcansky S., Coco R., Rivarola M.A., Bergada C. High incidence of thyroid disturbances in 49 children with Turner syndrome. J Pediatr. 111:1987;258-261
19. Larizza D., Martinetti M., Lorini R., Maghnie M., Dugoujon J.M., Cuccia Belvedere M., et al. Autoimmunity, HLA, Gm and Km polymorphisms in Turner's syndrome. Autoimmunity. 4:1989;69-78
20. Baranda L., Torres-Alvarez V., Moncada B., Portales-Pérez D., De la Fluente H., Layseca E., et al. Presence of activated lymphocytes in the peripheral blood of patients with halo nevi. J Am Acad Dermatol. 41:1999;567-572
21. Barona M.I., Arrunategui A., Falabella R., Alzate A. An epidemiologic case-control study in a population with vitiligo. J Am Acad Dermatol. 33:1995;621-625
22. Larizza D., Martinetti M., Lorini R., Dugoujon J.M., Tinelli C., Vitali L., et al. Parental segregation of autoimmunity in patients with Turner's syndrome: preferential paternal transmission? J Autoimmun. 12:1999;65-72
23. Terasaki P.I. Microdroplet assay for human blood lymphotoxin in histocompatibility testing. Terasaki P.I. Histocompatibility testing. 1965;171 National Academy of Sciences, Washington DC
24. Olerup O., Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 39:1992;225-235
25. Turner H.H. A syndrome of infantilism, congenital webbed neck and cubitus valgus. Endocrinology. 23:1938;566-578
26. Ullrich O. Uber typische kombinationsbilder multipler abartung. Z Kinderheilk. 49:1930;271-276
27. Lippe B. Turner's syndrome. Endocrinol Metab Clin North Am. 20:1991;121-152
28. Lemli L., Smith D.W. The XO syndrome: a study of the differentiated phenotype in 25 patients. J Pediatr. 63:1963;577-588
29. Sybert V. Turner syndrome. Cassidy S., Allanson J. Management of genetic syndromes. 2001;459-484 Wiley-Liss, New York
30. Pasquino A.M., Passeri F., Municchi G., Segni M., Pucarelli I., Larizza D., et al. Final height in Turner syndrome patients treated with growth hormone. Horm Res. 46:1996;269-272
31. Balducci R., Toscano V., Larizza D., Mangiantini D., Galasso C., Municchi G., et al. Effects of long-term growth hormone therapy on adrenal steroidogenesis in Turner syndrome. Horm Res. 49:1998;210-215
32. Wyatt D. Melanocytic in children treated with growth hormone. Pediatrics. 104:1999;1045-1049
33. Bourguignon J.P., Pierard G.E., Ernould C., Heinrichs C., Craen M., Rochiccioli P., et al. Effects of human growth hormone therapy on melanocytic naevi. Lancet. 34:1993;1505-1506
34. Zvulunov A., Wyatt D.T., Laud P.W., Esterly N.B. Lack of effect of growth hormone therapy on the count and density of melanocytic naevi in children. Br J Dermatol. 137:1997;545-548
35. Zvulunov A., Wyatt D.T., Rabinowitz L.G., Esterly N.B. Effect of growth hormone therapy on melanocytic naevi in survivors in childhood neoplasia. Arch Dermatol. 133:1997;795-796